newsfilter
← Latest News
GlobeNewswire·

Teva to Present at the Goldman Sachs Global Healthcare Conference

  • Teva Pharmaceutical Industries Ltd. announced that President & CEO Richard Francis will attend the Goldman Sachs Global Healthcare Conference.
  • The fireside chat is scheduled for Monday, June 8, 2026, at 8:00 A.M. Eastern Time.
  • Live webcasts will be available on Teva's Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.
  • Archived webcast versions will be accessible within 24 hours of the event's conclusion for up to 30 days.
  • Teva is transforming into an innovative biopharmaceutical company supported by its generics business, focusing on neuroscience, immunology, biosimilars, pharmacy brands, complex generic medicines, innovation, the "Pivot to Growth" strategy, product pipeline expansion, and cost savings.
  • The release includes forward-looking statements subject to risks such as generic product dependence, competition, intellectual property protection, significant indebtedness, regulatory matters, execution of the "Pivot to Growth" strategy, product commercialization, and investment results.
  • Contact information is provided for Teva Media Inquiries at TevaCommunicationsNorthAmerica@tevapharm.com and Investor Relations Inquiries at TevaIR@Tevapharm.com.